NRG Oncology Clinical Trials Development Core
Official title: NRG Oncology CTD Core
Funded at Nrg Oncology Foundation, INC. · NIH-11291691 · Data updated 2026-11-12
A core program that helps run and improve late-stage cancer clinical trials by providing leadership, data management, and oversight to ensure high-quality studies for patients with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nrg Oncology Foundation, INC. NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | April 17, 2014 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $4,058,141 |
| NIH project number | 2U10CA180868-12 |
| Project ID | NIH-11291691 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are cancer patients eligible for late-phase clinical trials or individuals who may participate in future multicenter studies through trial sites connected to the NRG network.
✕Less likely to help
Patients not eligible for clinical trials or without participating sites nearby may not directly benefit.
What this research studies
This grant supports a centralized team of physicians, statisticians, and administrators who design and manage multicenter cancer trials. It coordinates with data management, safety monitoring, and patient advocates to develop trials aligned with national mission goals. The Core works with CTEP and other NCTN groups to ensure timely, high-quality translational and clinical research opportunities for people facing cancer. The aim is to streamline trial development so patients can access innovative therapies through well-structured, rigorously monitored studies.
Why it matters
Potential benefit: If successful, this program could accelerate access to high-quality cancer trials and bring effective treatments to patients more quickly.
How similar studies have gone: Previous efforts in coordinated trial development and data monitoring have improved trial quality and speed in oncology networks.
Where this research is happening
-
Nrg Oncology Foundation, INC.
Philadelphia, United States Active
Researchers
- Principal investigator: Wolmark, Norman — Nrg Oncology Foundation, INC.
- Study coordinator: Wolmark, Norman
Related research
Other NIH-funded projects on the same topics.
-
NRG Oncology NCORP: Expanding Community Cancer Care and Trials
A national program to bring cancer trials and patient-reported outcomes to community clinics, improving access to cutting-edge care for people with cancer.
-
NRG Oncology Biospecimen Bank for Cancer Patients
A national cancer research program will collect, store, and link tumor and normal tissues with patient data to support advancing cancer treatments for adults.
-
NRG Oncology Member Core (supporting cancer trials)
A large network of cancer centers collaborates to run and manage cancer clinical trials, helping patients access cutting-edge treatments.
-
NRG Oncology Administrative Core supports multi-site cancer trials
This grant funds a centralized leadership and infrastructure core to run and coordinate large cancer clinical trials across many sites, helping ensure timely patient enrollment and high-quality study conduct.
-
NRG Oncology Network Center: Coordinating Innovative Cancer Trials
A large, patient-focused network coordinates and conducts trials to improve outcomes for adults with non-hematologic cancers such as breast, bladder, brain, and other tumors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.